Literature DB >> 15289827

Expression of heat shock proteins in human hepatocellular carcinoma after radiofrequency ablation in an animal model.

Gerd Schueller1, Joachim Kettenbach, Roland Sedivy, Helga Bergmeister, Anton Stift, Josef Fried, Michael Gnant, Johannes Lammer.   

Abstract

Since tumor cells are known to express heat shock proteins (HSPs) as a response to cellular stress, such as heat, our goal was to determine the expression of HSPs in human hepatocellular carcinoma (HCC) before and after percutaneous radiofrequency (RF) ablation using a rat model. In 12 nude rats, human HCC cells (SK-HEP-1) were inoculated subcutaneously. A total of 21 tumors were grown in the bilateral flanks of the rats. Of those, 19 were treated with percutaneous RF ablation (diameter of RF electrode, 18 gauge; RF ablation energy, 60-600 W; duration, 20-100 sec). To determine the extent of necrosis, and the cellular expression of HSP 70 and HSP 90, the tumors were excised within 6, 12 and 24 h after RF ablation, respectively. The extent of the coagulation necrosis and the expression of HSP 70 and 90 were evaluated. Linear regression analysis showed a significant correlation between the volume of coagulation necrosis and the RF energy applied. Before RF ablation, expression of HSP 70 and 90 was 0% and 0-30%, respectively. Following RF ablation, the maximum level of HSP 70 expression was 60%, and the maximum level of HSP 90 expression was 100%. The expression of HSP 70 and 90 in HCC is significantly increased by RF ablation. These findings are of particular importance in the host-tumor immune response and might be useful in forthcoming immunotherapeutical strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289827

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  13 in total

Review 1.  Thermal ablation of tumours: biological mechanisms and advances in therapy.

Authors:  Katrina F Chu; Damian E Dupuy
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

2.  Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation.

Authors:  Sebastian P Haen; Cécile Gouttefangeas; Diethard Schmidt; Andreas Boss; Stephan Clasen; Alexandra von Herbay; Bora Kosan; Hermann Aebert; Philippe L Pereira; Hans-Georg Rammensee
Journal:  Cell Stress Chaperones       Date:  2011-03-26       Impact factor: 3.667

Review 3.  Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment.

Authors:  Christopher Bastianpillai; Neophytos Petrides; Taimur Shah; Stephanie Guillaumier; Hashim U Ahmed; Manit Arya
Journal:  Tumour Biol       Date:  2015-09-30

Review 4.  Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer.

Authors:  Salvatore Paiella; Roberto Salvia; Roberto Girelli; Isabella Frigerio; Alessandro Giardino; Mirko D'Onofrio; Giulia De Marchi; Claudio Bassi
Journal:  Updates Surg       Date:  2016-08-18

5.  Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model.

Authors:  Wei Yang; Muneeb Ahmed; Beenish Tasawwar; Tatynana Levchenko; Rupa R Sawant; Vladimir Torchilin; S Nahum Goldberg
Journal:  J Control Release       Date:  2011-12-30       Impact factor: 9.776

6.  Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model.

Authors:  Wei Yang; Muneeb Ahmed; Beenish Tasawwar; Tatyana Levchenko; Rupa R Sawant; Michael Collins; Sabina Signoretti; Vladimir Torchilin; S Nahum Goldberg
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

7.  Percutaneous radiofrequency ablation for treatment of hepatoblastoma recurrence.

Authors:  Jingjing Ye; Qiang Shu; Minju Li; Tian-an Jiang
Journal:  Pediatr Radiol       Date:  2008-06-06

8.  Heat shock protein inhibitor, quercetin, as a novel adjuvant agent to improve radiofrequency ablation-induced tumor destruction and its molecular mechanism.

Authors:  Wei Yang; Ming Cui; Jungchieh Lee; Wei Gong; Song Wang; Jingjing Fu; Gongxiong Wu; Kun Yan
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

Review 9.  More than just tumor destruction: immunomodulation by thermal ablation of cancer.

Authors:  Sebastian P Haen; Philippe L Pereira; Helmut R Salih; Hans-Georg Rammensee; Cécile Gouttefangeas
Journal:  Clin Dev Immunol       Date:  2011-12-29

10.  Investigation of HIFU-induced anti-tumor immunity in a murine tumor model.

Authors:  Zhenlin Hu; Xiao Yi Yang; Yunbo Liu; Georgy N Sankin; Eric C Pua; Michael A Morse; H Kim Lyerly; Timothy M Clay; Pei Zhong
Journal:  J Transl Med       Date:  2007-07-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.